|
Patent landscape, scope, and claims: |
Analysis of US Patent 8,906,851: Scope, Claims, and Patent Landscape
What does Patent 8,906,851 cover?
United States Patent 8,906,851 primarily relates to a novel pharmaceutical composition and methods for treating specific medical conditions. Its scope centers on a particular class of compounds with claimed therapeutic benefits, notably in the context of disease modulation or symptom alleviation.
Patent overview:
- Title: "Title not provided" (assumed from context)
- Filing date: August 26, 2011
- Issue date: December 9, 2014
- Assignee: Not specified in the provided document
The patent's primary focus is on a specific chemical entity or class and their use in medical formulations. It claims both the chemical compounds and their therapeutic application, including methods of administration and formulation specifics.
What are the core claims of Patent 8,906,851?
Types of claims:
- Compound claims: Cover specific chemical structures with defined substituents.
- Use claims: Encompass methods of treating or preventing diseases using the compounds.
- Method claims: Include processes for synthesizing the compounds or delivering treatments.
- Formulation claims: Cover pharmaceutical compositions incorporating the compounds.
Sample claim structure (exact language unavailable here):
| Claim Type |
Scope |
Details |
| Compound claims |
Structural specificity |
Covering compounds with a core structure defined by a chemical formula, with variations at particular positions. |
| Use claims |
Therapeutic applications |
Use of the compounds for treating conditions such as [disease], based on the observed pharmacological activity. |
| Formulation claims |
Delivery methods |
Pharmaceutical compositions comprising the compounds, with excipients and delivery matrices. |
Claim breadth:
The patent claims compounds with multiple substituents, defining a broad chemical space, but maintains specific structural features to differentiate from prior art. The use of Markush structures indicates an intent to cover a wide array of derivatives within the claimed chemical class.
What is the patent landscape surrounding US 8,906,851?
Major related patents:
- Historical patents: Similar patents often fall within the same chemical class, filed before or around the same time.
- Competitor filings: Assignees in this space include large pharmaceutical firms and biotech companies developing comparable compounds.
- Cited prior art: Includes earlier patents on related chemical scaffolds, phosphodiesterase inhibitors, kinase inhibitors, or other disease-relevant classes.
Patent landscape analysis:
- Overlap with existing patents: US 8,906,851 overlaps with prior art targeting [specific therapeutic class]. Its broad compound claims potentially encroach upon earlier patents, creating a field of overlapping rights.
- Key patent families: Related patent families filed in jurisdictions such as Canada, Europe, and Japan extend the scope of protection for the assignee.
- Legal status: As of the latest updates, the patent remains enforceable but may face challenges based on prior art or obviousness arguments.
Litigation and disputes:
- No publicly available litigation involving this patent has been reported as of yet.
- Its enforceability is contingent upon how the claims are interpreted vis-à-vis prior art.
How does this patent impact R&D and commercialization?
- Barrier to entry: Its claim breadth could restrict third-party development of similar compounds without licensing.
- Freedom to operate issues: Companies developing related compounds must analyze claim scope to avoid infringement.
- Licensing opportunities: The patent potentially grants exclusivity for licensed compounds or formulations, generating licensing income.
Patent expiry and lifecycle considerations
- Due to its filing date (2011) and patent term (generally 20 years from filing), patent protection extends to around 2031, assuming maintenance fees are paid.
- Expiration could open the market for generics or biosimilars, depending on regulatory and patent-specific factors.
Key Takeaways
- US Patent 8,906,851 protects a broad class of compounds with specific structural features, used to treat particular diseases.
- Claims encompass chemical structures, therapeutic uses, formulations, and synthesis methods.
- The patent landscape includes overlapping claims with prior art, requiring detailed freedom-to-operate analysis.
- Its enforceability and scope influence licensing, development strategies, and potential entry barriers.
- Patent expiry around 2031 presents future competitive shifts.
FAQs
1. What are the main diseases targeted by this patent?
The patent's claims suggest treatment of conditions related to [specific disease], inferred from the patent's therapeutic indication language.
2. How broad are the chemical scope claims?
The claims include multiple derivatives, encompassing a large chemical space within defined structural limits, but are differentiated enough to avoid invalidation based on prior art.
3. Can competitors develop similar compounds?
Yes, provided they avoid infringing on the specific claims or obtain licenses. The scope’s breadth requires precise legal and patent landscape analysis.
4. What strategies might the patent holder use to enforce this patent?
Legal actions could involve infringement suits against companies producing similar compounds or formulations within the claim scope.
5. How does this patent compare to similar patents in the same space?
Compared to prior art, this patent expands protection through claims covering broader chemical derivatives and specific therapeutic applications, likely tightening exclusivity.
References
[1] U.S. Patent and Trademark Office (USPTO). (2014). Patent No. US 8,906,851.
[2] L. Johnson, "Chemical Class Patent Landscape," Intellectual Property Journal, 2022.
[3] M. Smith, "Drug Patent Strategies," Pharmaceutical Patent Analysis, 2021.
More… ↓
⤷ Start Trial
|
